PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer
Year: 2014
Type: review
Source: Pharmacology & Therapeutics
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
Awards: G1004564342, G1687339285, Molecular Mechanisms of Delayed Preconditioning, Cardioprotective Signaling following Phosphodiesterase-5 Inhibition, G3348589736, G4245952639, Cardioprotective Effects of PDE-5 Inhibitors, Protection against Doxorubicin-Induced Cardiomyopathy, G5702023534, ROS, Inflammation, and Cardioprotection in Type 2 Diabetes
OpenAlex ID: W2070737114
